FOXM1 inhibition: A novel therapeutic approach for small cell lung cancer

被引：0
|
作者：
Khan, Md Arafat
Khan, Parvez
Fatima, Mahek
Rehman, Asad Ur
Maurya, Shailendra Kumar
Mohiuddin, Sameer
Venkata, Ramakanth Chirravuri
Cox, Jesse L.
Kim, Sung Hoon
Katzenellenbogen, Benita S.
Katzenellenbogen, John A.
Ganti, Apar K.
Batra, Surinder K.
Nasser, Mohd Wasim
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1476
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1476
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Involvement of FoxM1 in Non-Small Cell Lung Cancer Recurrence
    Xu, Nuo
    Wu, Sheng-Di
    Wang, Hao
    Wang, Qun
    Bai, Chun-Xue
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (09) : 4739 - 4743
  • [2] FoxM1: a novel tumor biomarker of lung cancer
    Zhang, Jia
    Zhang, Jing
    Cui, Xiaohai
    Yang, Ya
    Li, Min
    Qu, Jingkun
    Li, Junhai
    Wang, Jiansheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (03): : 3136 - 3140
  • [3] Expression and functional characterization of FOXM1 in non-small cell lung cancer
    Zhang, Yan
    Qiao, Wen-bin
    Shan, Li
    ONCOTARGETS AND THERAPY, 2018, 11 : 3385 - 3393
  • [4] Prognostic significance of FoxM1 expression in non-small cell lung cancer
    Sun, Qing
    Dong, Min
    Chen, Yujuan
    Zhang, Jiawei
    Qiao, Jinpeng
    Guo, Xuedan
    JOURNAL OF THORACIC DISEASE, 2016, 8 (06) : 1269 - 1273
  • [5] FOXM1 Inhibition Enhances the Therapeutic Outcome of Lung Cancer Immunotherapy by Modulating PD-L1 Expression and Cell Proliferation
    Madhi, Hamadi
    Lee, Jeon-Soo
    Choi, Young Eun
    Li, Yan
    Kim, Myoung Hee
    Choi, Yongdoo
    Goh, Sung-Ho
    ADVANCED SCIENCE, 2022, 9 (29)
  • [6] Clinical significance and functional roles of FoxM1 in non-small cell lung cancer
    Xu, Nuo
    Jia, Deshui
    Chen, Wenfeng
    Ge, Di
    Bai, Chunxue
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [7] FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis
    Sheng-Kai Liang
    Chia-Chan Hsu
    Hsiang-Lin Song
    Yu-Chi Huang
    Chun-Wei Kuo
    Xiang Yao
    Chien-Cheng Li
    Hui-Chen Yang
    Yu-Ling Hung
    Sheng-Yang Chao
    Shun-Chi Wu
    Feng-Ren Tsai
    Jen-Kun Chen
    Wei-Neng Liao
    Shih-Chin Cheng
    Tsui-Chun Tsou
    I-Ching Wang
    Oncogene, 2021, 40 : 4847 - 4858
  • [8] FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis
    Liang, Sheng-Kai
    Hsu, Chia-Chan
    Song, Hsiang-Lin
    Huang, Yu-Chi
    Kuo, Chun-Wei
    Yao, Xiang
    Li, Chien-Cheng
    Yang, Hui-Chen
    Hung, Yu-Ling
    Chao, Sheng-Yang
    Wu, Shun-Chi
    Tsai, Feng-Ren
    Chen, Jen-Kun
    Liao, Wei-Neng
    Cheng, Shin-Chin
    Tsou, Tsui-Chun
    Wang, I-Ching
    ONCOGENE, 2021, 40 (30) : 4847 - 4858
  • [9] BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
    Zhang, Zhenfeng
    Ma, Pengfei
    Jing, Ying
    Yan, Ying
    Cai, Mei-Chun
    Zhang, Meiying
    Zhang, Shengzhe
    Peng, Huixin
    Ji, Zhi-Liang
    Di, Wen
    Gu, Zhenyu
    Gao, Wei-Qiang
    Zhuang, Guanglei
    THERANOSTICS, 2016, 6 (02): : 219 - 230
  • [10] FoxM1 mediated resistance to gefitinib in non-small-cell lung cancer cells
    Xu, Nuo
    Zhang, Xin
    Wang, Xun
    Ge, Hai-yan
    Wang, Xiao-ying
    Garfield, David
    Yang, Ping
    Song, Yuan-lin
    Bai, Chun-xue
    ACTA PHARMACOLOGICA SINICA, 2012, 33 (05) : 675 - 681
12345